About Sterling Biotech
Sterling Biotech is a company based in Mumbai (India) founded in 1985 was acquired by Perfect Day in April 2022. The company has 249 employees as of March 27, 2025. Sterling Biotech operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Mumbai, India
- Employees 249 as on 27 Mar, 2025
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sterling Biotech Limited
- Date of Incorporation 23 Mar, 1985
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$55.69 M (USD)7.51as on Mar 31, 2024
-
Net Profit
-$2.25 M (USD)-100.32as on Mar 31, 2024
-
EBITDA
$7.72 M (USD)12.73as on Mar 31, 2024
-
Latest Funding Round
Not available
- Investors
-
Employee Count
249
as on Mar 27, 2025
-
Acquired by
Perfect Day
(Apr 20, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Sterling Biotech
Detailed funding history for Sterling Biotech
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Sterling Biotech
Sterling Biotech has secured backing from 1 investor. Prominent investors backing the company include Perfect Day.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Dairy alternatives are produced via fermentation of plant-based sugars.
|
Locked | Locked | Locked |
Investor details for Sterling Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sterling Biotech
Investment portfolio details for Sterling Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sterling Biotech
Detailed financials for Sterling Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sterling Biotech Comparisons
Peer comparison for Sterling Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sterling Biotech
Sterling Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Sterling Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sterling Biotech
Complete news archive for Sterling Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sterling Biotech
Sterling Biotech was founded in 1985.
Sterling Biotech is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
As of Mar 27, 2025, the latest employee count at Sterling Biotech is 249.
Annual revenue of Sterling Biotech is $55.69M as on Mar 31, 2024.
Sterling Biotech is a drug API manufacturer. The company also manufactures gelatin from animal bones. Their capabilities include a research centre, pilot plant for scale up studies, facility of bioreactors and a range of down streaming process equipments. The Company produces various pharmaceutical products, such as Lovastatin, a cholesterol lowering drug, and oncology products. Its anti-cancer products include DOXO Rubicin, an anti-cancer chemotherapy drug; IDARUBICIN, an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug; Daunorubicin, which is used to treat acute lymphocytic and myelocyticleukemias; IMATINIB, a drug used to treat certain cancers, and EPI Rubicin, an anthracycline drug used for chemotherapy. The Companys other products include DACARBAZINE, which is used to treat Hodgkin disease and malignant melanoma; Temozolamide, an oral alkylating agent used for the treatment of Grade IV astrocytoma, and Simvastatin, a lipid lowering drug. Sterling Biotechs manufacturing facility at Masar, Gujarat, is at par with international standards. It complies with cGMP norms complying to the standards of WHO and is in the process of getting CEP for the active pharmaceutical ingredient Epirubicin , Lovastatin;.
Sterling Biotech's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Sterling Biotech has 1 investor. Key investors include Perfect Day.